MIGNARRI, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 6.598
EU - Europa 4.277
AS - Asia 1.981
SA - Sud America 340
Continente sconosciuto - Info sul continente non disponibili 179
AF - Africa 132
OC - Oceania 3
Totale 13.510
Nazione #
US - Stati Uniti d'America 6.522
GB - Regno Unito 1.273
RU - Federazione Russa 777
CN - Cina 688
SG - Singapore 628
IT - Italia 533
IE - Irlanda 477
BR - Brasile 286
UA - Ucraina 278
SE - Svezia 240
DE - Germania 213
FR - Francia 196
VN - Vietnam 177
HK - Hong Kong 154
FI - Finlandia 100
ZA - Sudafrica 81
KR - Corea 73
ES - Italia 59
BD - Bangladesh 55
TR - Turchia 53
CA - Canada 40
IN - India 34
NL - Olanda 29
PL - Polonia 26
BE - Belgio 23
PK - Pakistan 20
IQ - Iraq 19
MX - Messico 19
JP - Giappone 16
AR - Argentina 15
LT - Lituania 11
MA - Marocco 10
SA - Arabia Saudita 10
IL - Israele 9
CO - Colombia 8
DZ - Algeria 8
EG - Egitto 8
ID - Indonesia 8
NG - Nigeria 7
PE - Perù 7
VE - Venezuela 7
EC - Ecuador 6
EU - Europa 6
SK - Slovacchia (Repubblica Slovacca) 6
CI - Costa d'Avorio 5
CZ - Repubblica Ceca 5
GR - Grecia 5
KE - Kenya 4
KZ - Kazakistan 4
PT - Portogallo 4
TN - Tunisia 4
AT - Austria 3
AZ - Azerbaigian 3
BG - Bulgaria 3
BO - Bolivia 3
HN - Honduras 3
IR - Iran 3
JM - Giamaica 3
MD - Moldavia 3
PH - Filippine 3
PY - Paraguay 3
SV - El Salvador 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
CL - Cile 2
ET - Etiopia 2
HU - Ungheria 2
JO - Giordania 2
KW - Kuwait 2
LB - Libano 2
MK - Macedonia 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
RO - Romania 2
SI - Slovenia 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
KG - Kirghizistan 1
LV - Lettonia 1
LY - Libia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 13.337
Città #
Southend 1.131
Dallas 1.092
Fairfield 675
Menlo Park 504
Dublin 475
Ashburn 431
Woodbridge 337
Singapore 328
Chandler 273
Wilmington 253
Seattle 249
Houston 246
Jacksonville 243
Moscow 241
Santa Clara 237
Cambridge 228
San Jose 216
Beijing 197
Ann Arbor 190
Milan 159
Hong Kong 150
Siena 95
Princeton 93
Hefei 79
Johannesburg 79
Los Angeles 74
Council Bluffs 71
Seoul 71
Nanjing 70
New York 64
The Dalles 60
Ho Chi Minh City 55
Munich 54
Málaga 52
Helsinki 44
Lauterbourg 44
Boardman 42
Lancaster 42
Rome 42
San Diego 40
Izmir 33
Buffalo 31
Hanoi 31
Dong Ket 29
Columbus 28
San Mateo 26
Orem 24
Nanchang 23
Changsha 22
London 22
Warsaw 22
Hebei 20
Tianjin 19
Shenyang 18
Figino 17
Florence 17
Shanghai 17
São Paulo 17
Brussels 16
Dearborn 15
Chicago 14
Jiaxing 14
San Francisco 14
Tokyo 14
Turku 14
Redondo Beach 13
Toronto 13
Düsseldorf 12
Montreal 12
Norwalk 12
Frankfurt am Main 11
Phoenix 11
Boston 10
Brooklyn 10
Kunming 10
Turin 10
Belo Horizonte 9
Stockholm 9
Atlanta 8
Bologna 8
Guangzhou 8
Hangzhou 8
Jinan 8
Bengaluru 7
Da Nang 7
Denver 7
Manchester 7
Waanrode 7
Washington 7
Abuja 6
Baghdad 6
Brasília 6
Bratislava 6
Lahore 6
Mestre 6
Mumbai 6
Nuremberg 6
Richland 6
Rio de Janeiro 6
Abidjan 5
Totale 9.832
Nome #
An atypical case of Creutzfeldt-Jakob disease mimicking frontotemporal dementia: genotypic influence and clinical implications 485
A CASE OF CEREBROTENDINOUS XANTHOMATOSIS PRESENTING WITH PARKINSONISM IN THE SEVENTH DECADE 409
Double trouble? Progranulin mutation and C9ORF72 repeat expansion in a case of primary non-fluent aphasia 326
A mimic of first dorsal interosseus atrophy revealed by ultrasound study 325
Cerebellum and neuropsychiatric disorders: insights from ARSACS 322
Eye movement abnormalities in a patient with Zellweger spectrum disorder 293
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 291
Cerebellar hypometabolism with normal structural findings in Cerebrotendinous xanthomatosis. A case report 291
Zellweger Spectrum Disorder with Mild Phenotype Caused by PEX2 Gene Mutations 290
The role of dentate nuclei in human oculomotor control: Insights from cerebrotendinous xanthomatosis 285
Narcolepsy is a common phenotype in HSAN IE and ADCA-DN 283
Mitochondrial dysfunction in hereditary spastic paraparesis with mutations in DDHD1/SPG28 276
Demyelinating polyneuropathy in a case of anti-LGI1 encephalitis 272
Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation. Six-year MRI follow-up 266
Temporal lobe abnormalities in neurosyphilis 265
Two-year follow-up after chelating therapy in a patient with adult-onset parkinsonism and hypermanganesaemia due to SLC30A10 mutations 261
The first Italian patient with oculopharyngodistal myopathy: Case report and considerations on differential diagnosis. 252
Imaging of the thymus in myotonic dystrophy type 1 252
Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis. 245
Polyneuropathy with demyelinating changes in Churg–Strauss syndrome: an unusual association 243
Primary familial brain calcification: Genetic analysis and clinical spectrum. 242
A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. 239
The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression 236
Mutations in SLC30A10 Cause Parkinsonism and Dystonia with Hypermanganesemia, Polycythemia, and Chronic Liver Disease. 227
Hand muscles corticomotor excitability in hereditary spastic paraparesis type 4. 227
Electrodiagnosis in cranial botulism 225
Neuroendocrine lung cancer in a patient with limbic encephalopathy due to anti-Hu antibodies: A rare association not to be missed 225
First report of an Iraqi Kurdish CADASIL patient. 225
Myoclonus epilepsy, retinitis pigmentosa, leukoencephalopathy and cerebral calcifications associated with a novel m.5513G>A mutation in the MT-TW gene 225
Clinical Features and Outcome of the Guillain–Barre Syndrome: A Single-Center 11-Year Experience 224
Hereditary spastic paraplegia type 5: a potentially treatable disorder of cholesterol metabolism 224
Long-Term Bone Density Evaluation in Cerebrotendinous Xanthomatosis: Evidence of Improvement after Chenodeoxycholic Acid Treatment. 223
Parkinsonism as neurological presentation of late-onset cerebrotendinous xanthomatosis 222
Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid. 219
Lithium neurotoxicity mimicking rapidly progressive dementia 218
Brachial plexopathy due to breast cancer metastases: electrophysiological and imaging findings 216
Next Generation Molecular Diagnosis of Hereditary Spastic Paraplegias: An Italian Cross-Sectional Study 212
A Novel CSF1R Mutation in a Patient with Clinical and Neuroradiological Features of Hereditary Diffuse Leukoencephalopathy with Axonal Spheroids 210
Discordant manifestations in Italian brothers with GNE myopathy 209
SPG5 siblings with different phenotypes showing reduction of 27-hydroxycholesterol after simvastatin-ezetimibe treatment 175
From the liver to the brain: manganese matters : Focus on cirrhosis-related Parkinsonism. 173
null 155
null 146
null 144
null 143
Enlarging brain xanthomas in a patient with cerebrotendinous xanthomatosis. 131
Mitochondrial recessive ataxia syndrome: A neurological rarity not to be missed. 128
Ataxia with oculomotor apraxia type 2: not always an easy diagnosis 126
null 123
The safety and effectiveness of chenodeoxycholic acid treatment in patients withcerebrotendinous xanthomatosis:two retrospective cohort studies 120
null 119
Erratum: Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1 (Scientific Reports (2016) 6 (38174) DOI: 10.1038/srep38174) 119
Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis 118
Correction to: Monoallelic KIF1A-related disorders: a multicenter cross sectional study and systematic literature review 113
Correction to: Monoallelic KIF1A-related disorders: a multicenter cross sectional study and systematic literature review (Journal of Neurology, (2022), 269, 1, (437-450), 10.1007/s00415-021-10792-3) 111
Primary familiall brain calcification caused by MYORG mutations in an Italian family 111
Familial Alzheimer’s disease associated with heterozygous NPC1 mutation 109
null 109
null 108
null 107
Oculomotor features in SCA27B patients 104
Primary familial brain calcification with mild phenotype due to a new PDGFB mutation 98
null 92
Treatment of SPG5 with cholesterol-lowering drugs 76
Neuromuscular excitability changes produced by sustained voluntary contraction and response to mexiletine in myotonia congenita 73
Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion 71
Primary familial brain calcification: update on molecular genetics 65
Syntactic complexity in Mild Cognitive Impairment due to Alzheimer’s disease (MCI-AD): long-distance dependencies and working memory in comprehension of relative clauses 63
Totale 13.510
Categoria #
all - tutte 36.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022666 0 89 39 41 47 26 49 17 48 85 76 149
2022/2023981 58 66 133 125 106 192 21 77 105 58 22 18
2023/2024677 36 21 58 30 17 192 246 15 3 13 4 42
2024/20251.479 17 73 136 60 227 102 64 66 130 42 153 409
2025/20264.197 283 532 910 434 703 114 316 117 139 206 94 349
2026/2027196 167 29 0 0 0 0 0 0 0 0 0 0
Totale 13.510